Vasoactive Intestinal Peptide Tumor

Vasoactive Intestinal Peptide Tumor – General Information

Vasoactive Intestinal Peptide Tumor – Symptoms

Vasoactive Intestinal Peptide Tumor – Treatment

The first stage in treating Vasoactive Intestinal Peptide Tumor is the prompt replacement of fluid and electrolyte losses. In most cases, the specific signs and symptoms of the electrolyte loss can include cardiac arrhythmias, neuromuscular deficits, profound shock, and cardiovascular collapse. The fluid that is used to replace these losses is usually an isotonic electrolyte solution that contains adequate doses of potassium, sodium and base. If the patient has been diagnosed with the tumor, the first treatment option is complete surgical removal. If the tumor can not be removed completely, the second treatment option is a procedure called surgical debulking, which can provide a palliative effect. In treating Vasoactive Intestinal Peptide Tumor the most common medicine used is Sandostatin. This type of drug is an artificial protein that is considered similar to a hormone in the patient’s body called somatostatin. The medicine acts by lowering the concentration of certain substances in the patient’s body, which can include insulin and glucagons, both involved in regulating the patient’s blood sugar levels, growth hormone, and certain chemicals involved in digestion. This medicine is also used to treat acromegaly and to reduce flushing episodes and watery diarrhea triggered by malignant tumors, carcinoid syndromes or tumors called Vasoactive Intestinal Peptide Tumors.

There are cases in which the doctor can use the medicine in other purposes than those listed in the medication guide. Before administrating the Sandostatin medicine the doctor should know if the patient suffers from diabetes, gallbladder disorders, kidney disease or a thyroid dysfunction. One of the contraindications for this medicine is that it should not be administrated in combination with cyclosporine, a medicine that can be prescribed as Neoral, Sandimmune or Gengraf.

To treat Vasoactive Intestinal Peptide Tumor, Sandostatin is administrated using an injection under the patient’s skin or blood vessel. It is very important not to inject yourself the medicine if you are patient not fully aware of how to apply it. There are cases in which the medicine has not been administered properly and thus, the patient may experience certain side effects that can include severe stomach pain, fever, bloating, vomiting, nausea, and jaundice, characterized by yellowing of the patient’s skin or eye. There are some tests with the help of which the doctor can know if the medicine is dealing with Vasoactive Intestinal Peptide Tumor and can order some tests of the patient’s blood or urine. To reduce the discomfort caused by the medicine administration, you can put it in the refrigerator and keep it there for about 30 minutes, but without allowing the medicine to freeze. It is very important to let the medicine reach the room temperature before administrating it, but it is also important to never warm the medicine in hot water or a microwave. There are cases in which the patient’s organism did not respond to the medicine and he can experience certain symptoms such as slow or irregular heartbeats, stomach pain, pancreatitis, thyroid problems, low blood sugar or high blood sugar, which can lead to the worsening of the condition, eventually causing death.